Serotonin augmentation therapy by escitalopram has minimal effects on amyloid-β levels in early-stage Alzheimer’s-like disease in mice

Full text: Download

Publisher: BMC (part of Springer Nature)

Preprint: archiving allowed. Upload

Postprint: archiving allowed. Upload

Published version: archiving allowed. Upload

Policy details (opens in a new window). Data provided by SHERPA/RoMEO